Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions

1. Herzog, T.J.
2. Wahab, S.A.
3. Mirza, M.R.
4. Pothuri, B.
5. Vergote, I.
6. Graybill, W.S.
7. Malinowska, I.A.
8. York, W.
9. Hurteau, J.A.
10. Gupta, D.
11. González-Martin, A.
12. Monk, B.J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1136/IJGC-2023-004605 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus